Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Cynthia Y. Truong

Mutation Ensemble for Response to Programmed Cell Death 1 Inhibition in Thymic Carcinoma

Journal of Thoracic Oncology

English

Related publications

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics

English

Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors

Frontiers in Oncology

Cancer Research

Oncology

2019

English

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma-Authors' Reply

Alimentary Pharmacology and Therapeutics

English

The Metastatic Dissemination of a Squamous Cell Carcinoma Arising From an Epidermal Cyst and Subsequent Failure to Respond to Programmed Death 1 Inhibition

JAAD Case Reports

Dermatology

2019

English

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

English

Concordance Among Four Commercially Available, Validated Programmed Cell Death Ligand-1 Assays in Urothelial Carcinoma

English

Complete and Sustained Response of Brain Metastases to Programmed Death 1 Antibody Monotherapy in Treatment-Naive Programmed Death Ligand 1–Positive Lung Cancer

Journal of Thoracic Oncology

English

Device Genetics for Programmed Cell Death

Journal of Japanese Society for Extremophiles

2008

English

Indoleamine 2,3-Dioxygenase 1 and Programmed Cell Death-Ligand 1 Co-Expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Cynthia Y. Truong

Mutation Ensemble for Response to Programmed Cell Death 1 Inhibition in Thymic Carcinoma

Related publications

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma

Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma-Authors' Reply

The Metastatic Dissemination of a Squamous Cell Carcinoma Arising From an Epidermal Cyst and Subsequent Failure to Respond to Programmed Death 1 Inhibition

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

Concordance Among Four Commercially Available, Validated Programmed Cell Death Ligand-1 Assays in Urothelial Carcinoma

Complete and Sustained Response of Brain Metastases to Programmed Death 1 Antibody Monotherapy in Treatment-Naive Programmed Death Ligand 1–Positive Lung Cancer

Device Genetics for Programmed Cell Death

Indoleamine 2,3-Dioxygenase 1 and Programmed Cell Death-Ligand 1 Co-Expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy